about
Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studiesCardiovascular thrombotic events in controlled, clinical trials of rofecoxibWorld Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) GuidelinesDecision-Making about Healthcare Related Tests and Diagnostic Strategies: User Testing of GRADE Evidence TablesUse of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol.Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease.The Saudi clinical practice guideline for the diagnosis of the first deep venous thrombosis of the lower extremity.Treatment of idiopathic pulmonary fibrosis: a network meta-analysis.The Saudi Clinical Practice Guideline for the treatment of venous thromboembolism. Outpatient versus inpatient management.Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.Pneumonia observational incidence and treatment: a multidisciplinary process improvement study.The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panelsThe safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis.Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise.The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in medical and critically ill patients.GRADE system: new paradigm.Diagnosis and Rationale for Action Against Cow's Milk Allergy (DRACMA): a summary report.GRADE guidelines: 9. Rating up the quality of evidence.GRADE guidelines: 8. Rating the quality of evidence--indirectness.GRADE guidelines: 5. Rating the quality of evidence--publication bias.GRADE guidelines: 7. Rating the quality of evidence--inconsistency.GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes.How DRACMA changes clinical decision for the individual patient in CMA therapy.Formatting modifications in GRADE evidence profiles improved guideline panelists comprehension and accessibility to information. A randomized trial.GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes.GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes.Applying Grading of Recommendations Assessment, Development and Evaluation (GRADE) to diagnostic tests was challenging but doable.Improving GRADE evidence tables part 2: a systematic survey of explanatory notes shows more guidance is needed.GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health.MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis.Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure.Simvastatin given for 3 days can inhibit thrombin generation and activation of factor V and enhance factor Va inactivation in hypercholesterolemic patients.Glycemic control in the ICU: a multicenter survey.GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT.The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses.GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations.246 Assessment of the Quality of Methodological Rigour and Reporting of Clinical Practice Guidelines for the Management of Allergic Rhinitis—Qugar Study.The global impact of the DRACMA guidelines cow’s milk allergy clinical practice.Decision making about healthcare-related tests and diagnostic test strategies. Paper 2: a review of methodological and practical challenges.Decision making about healthcare-related tests and diagnostic test strategies. Paper 5: a qualitative study with experts suggests that test accuracy data alone is rarely sufficient for decision making.
P50
Q26852067-DFA5861E-6160-464C-8D81-B85364100776Q28193519-67DA814C-F30F-4F23-B404-849752032D3EQ28282226-D80709AF-381A-481F-8DB8-A7520DF467D5Q28611072-76EAC5EE-9CED-4430-8BD8-921E853E344AQ31088061-7A7934EA-7BBD-4069-9452-1A902E07FEF6Q34692868-8AD8DF18-8F20-447C-BCA0-9141E2C7E22AQ34866266-070D8A6E-5BB9-4107-BF0E-11419DC604C9Q35914125-782F37E3-7346-4727-A07A-F26F1218840DQ35996203-A983CDAA-C236-4983-B83F-1AF519A28E0FQ36661809-7DFFAA45-D09C-43CD-AC70-9E38F65357CCQ36802191-66BE115A-25FE-44B5-9CE7-20CE9E816429Q37097183-25BF184B-8AD5-4F57-88AC-7B691835CCC5Q37262689-8DE93F19-36EF-4A91-8633-1CF34562060CQ37591576-CB6AAE71-2066-4C11-A781-AA42C9141090Q37637711-384D8372-859F-4649-93C3-78DAF025B683Q37770848-4FA7B969-7BA1-46E9-8A38-6F8AA1154577Q37816624-74B52C98-B07D-4AC1-B990-A6808B9BDDEEQ37908614-93ACF2A1-939F-49C4-BEF3-8C34792BA31EQ37908616-FCF4AD89-E65F-4FB5-AFC9-9A51CDB98AB3Q37908618-7C499757-C3C8-483A-9B65-3109CF9AFB2CQ37908778-0EDF79C0-27EE-4AFD-B60E-3D61E263A4AEQ38006189-F4B81FB9-D072-42E4-9B34-F105D8EA91B0Q38006409-02739815-75B8-42D5-B9A5-FDFA5B32DC28Q38008068-8619EA8C-4E34-48BC-9458-7198BF994803Q38011509-6B130D2A-5D1E-4346-8544-4166AA798EC2Q38057046-1F76A7EC-59EB-4D52-97DD-38E3923BF1CBQ38203995-B38804C3-7979-440A-BE54-4ADCF7C581CEQ38704710-04AF890C-4726-45B7-84C8-378EE866D914Q38756652-4A647035-56FA-4568-89E6-BEC1425669DCQ38853489-93992C8A-2A36-4EB0-82FE-040364859330Q40062246-96412387-8919-49EA-BB34-551E048BD162Q40073814-AA1DC771-8C62-4771-9C4E-5173402E6DE5Q40521325-33765C20-5DA9-4654-8112-A6574C241A51Q40551444-CD00B71B-BC4C-47DA-AD91-F1F408FB795BQ44571284-CD16CE8D-07DC-46F3-B100-8DABB545E6F0Q45412715-4F3F62E2-73C3-4693-BC2B-F9BA9892DB3AQ46689123-D95D4B01-0497-4F64-BCB3-3DF1E33C5114Q47099237-183D087A-54B2-4C18-8998-B0A3158A87FFQ47692158-F0973083-B4C0-4A82-8282-E26AB32F12CEQ47974626-ED7EABC3-833C-4F81-8739-C85524644AEA
P50
name
Jan Brozek
@en
Jan Brozek
@nl
type
label
Jan Brozek
@en
Jan Brozek
@nl
prefLabel
Jan Brozek
@en
Jan Brozek
@nl